Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
oral
|
| gptkbp:alsoKnownAs |
gptkb:SAR245409
gptkb:voxtalisib |
| gptkbp:CASNumber |
1223397-11-2
|
| gptkbp:clinicalTrialPhase |
gptkb:NCT01396499
gptkb:NCT01449370 gptkb:NCT01596270 Phase II |
| gptkbp:developedBy |
gptkb:Sanofi
gptkb:Exelixis |
| https://www.w3.org/2000/01/rdf-schema#label |
XL518
|
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
PI3K inhibitor
mTOR inhibitor |
| gptkbp:target |
gptkb:PI3K_beta
gptkb:PI3K_gamma gptkb:PI3K_delta gptkb:PI3K_alpha gptkb:mTOR |
| gptkbp:UNII |
1Y1FQ8V5QF
|
| gptkbp:bfsParent |
gptkb:Cotellic
|
| gptkbp:bfsLayer |
7
|